文献速递细菌感染、耐药与抗菌药物

量化亚洲城市社区环境中儿童腹泻病的抗菌药物可及性与使用情况

Quantifying antimicrobial access and usage for paediatric diarrhoeal disease in an urban community setting in Asia.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

在越南城市社区采用混合方法评估儿童腹泻抗菌药物可及性与使用。药房密度为每平方公里15.7家,模拟客户发现8%和22%的药房分别出售用于儿童水样便和黏液便的抗菌药物;81%和88%的照护者首选专科医院。1至<5岁儿童每年至少19%的腹泻发作接受抗菌药物,医院使用量约为社区的10倍。

要点

  • 社区药房密度高(15.7家/km²,每1316人一家),但仅8%和22%的药房出售儿童腹泻抗菌药物。
  • 多数照护者(81%水样便、88%黏液便)首选专科医院,而非社区药房。
  • 1至<5岁儿童每年至少19%的腹泻发作使用抗菌药物,医院使用量约为社区的10倍。

核心结论

  • 社区抗菌药物使用数据对耐药流行的影响受到质疑,并强调需要对所有有处方权的专业人员开展教育和制定指南。

研究设计与样本

  • 采用混合方法(地理空间映射、模拟客户、医疗保健利用、纵向队列)评估社区抗菌药物可及性并量化儿童腹泻抗菌药物使用。
  • 研究地点为越南城市社区。

主要发现

  • 研究区域药房密度为15.7家/km²(每1316人一家药房)。
  • 模拟客户法显示,8%(3/37)和22%(8/37)的药房分别出售用于儿童水样便和黏液便的抗菌药物。
  • 81%(319/396)和88%(347/396)的应答者将专科医院列为水样便和黏液便治疗的前三选择之一。
  • 1至<5岁儿童每年至少19%(2688/14427)的腹泻发作接受抗菌药物。
  • 医院抗菌药物使用量几乎是社区的10倍。

临床怎么用

  • 作者认为,社区抗菌药物使用对耐药的影响受到质疑,并强调需要对所有有处方权的专业人员开展教育和制定指南。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antimicrobial-resistant infections are a major global health issue. Ease of antimicrobial access in developing countries is proposed to be a key driver of the antimicrobial resistance (AMR) epidemic despite a lack of community antimicrobial usage data. METHODS: Using a mixed-methods approach (geospatial mapping, simulated clients, healthcare utilization, longitudinal cohort) we assessed antimicrobial access in the community and quantified antimicrobial usage for childhood diarrhoea in an urban Vietnamese setting. RESULTS: The study area had a pharmacy density of 15.7 pharmacies/km2 (a pharmacy for every 1316 people). Using a simulated client method at pharmacies within the area, we found that 8% (3/37) and 22% (8/37) of outlets sold antimicrobials for paediatric watery and mucoid diarrhoea, respectively. However, despite ease of pharmacy access, the majority of caregivers would choose to take their child to a healthcare facility, with 81% (319/396) and 88% (347/396) of responders selecting a specialized hospital as one of their top three preferences when seeking treatment for watery and mucoid diarrhoea, respectively. We calculated that at least 19% (2688/14427) of diarrhoea episodes in those aged 1 to <5 years would receive an antimicrobial annually; however, antimicrobial usage was almost 10 times greater in hospitals than in the community. CONCLUSIONS: Our data question the impact of community antimicrobial usage on AMR and highlight the need for better education and guidelines for all professionals with the authority to prescribe antimicrobials.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Thi Quynh Nhi L, de Alwis R, Khanh Lam P, et al. Quantifying antimicrobial access and usage for paediatric diarrhoeal disease in an urban community setting in Asia. J Antimicrob Chemother. 2018. PMID: 29982636. doi:10.1093/jac/dky231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。